Grufity logo
Grufity logo

Latest ALETHEA CAPITAL MANAGEMENT, LLC Stock Portfolio

$194Million– No. of Holdings #13

ALETHEA CAPITAL MANAGEMENT, LLC Performance:
2026 Q1: -6.09%YTD: -6.09%2025: 73.32%
Performance for 2026 Q1 is -6.09%, and YTD is -6.09%, and 2025 is 73.32%.

About ALETHEA CAPITAL MANAGEMENT, LLC and 13F Hedge Fund Stock Holdings

ALETHEA CAPITAL MANAGEMENT, LLC is a hedge fund based in San Diego, CA. On 2026-05-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, ALETHEA CAPITAL MANAGEMENT, LLC reported an equity portfolio of $194.9 Millions as of 31 Mar, 2026.

The top stock holdings of ALETHEA CAPITAL MANAGEMENT, LLC are AXSM, BIL, KURA. The fund has invested 56.3% of it's portfolio in AXSOME THERAPEUTICS INC. and 30.1% of portfolio in SPDR SERIES TRUST.

The fund managers got completely rid off AVIDITY BIOSCIENCES INC (RNA), CIDARA THERAPEUTICS INC (CDTX) and INVESCO EXCHANGE TRADED FD T (CSD) stocks. They significantly reduced their stock positions in STATE STR SPDR S&P 500 ETF T (SPY), AXSOME THERAPEUTICS INC. (AXSM) and ISHARES TR (IJR). ALETHEA CAPITAL MANAGEMENT, LLC opened new stock positions in ATRIUM THERAPEUTICS INC, WELLS FARGO & CO (WFC) and GRAPHIC PACKAGING HLDG CO (GPK). The fund showed a lot of confidence in some stocks as they added substantially to SPDR SERIES TRUST (BIL) and KURA ONCOLOGY INC (KURA).
ALETHEA CAPITAL MANAGEMENT, LLC Equity Portfolio Value
Last Reported on: 13 May, 2026

ALETHEA CAPITAL MANAGEMENT, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that ALETHEA CAPITAL MANAGEMENT, LLC made a return of -6.09% in the last quarter. In trailing 12 months, it's portfolio return was 37.97%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
atrium therapeutics inc585,044
wells fargo & co480,048
graphic packaging hldg co162,320
New stocks bought by ALETHEA CAPITAL MANAGEMENT, LLC

Additions

Ticker% Inc.
spdr series trust170
kura oncology inc7.5
Additions to existing portfolio by ALETHEA CAPITAL MANAGEMENT, LLC

Reductions

Ticker% Reduced
state str spdr s&p 500 etf t-98.64
axsome therapeutics inc.-2.93
ishares tr-1.26
ALETHEA CAPITAL MANAGEMENT, LLC reduced stake in above stock

Sold off

Ticker$ Sold
avidity biosciences inc-32,179,100
cidara therapeutics inc-1,022,720
invesco exchange traded fd t-212,899
ALETHEA CAPITAL MANAGEMENT, LLC got rid off the above stocks

Sector Distribution

ALETHEA CAPITAL MANAGEMENT, LLC has about 65.7% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare65.7
Others33.8

Market Cap. Distribution

ALETHEA CAPITAL MANAGEMENT, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • UNALLOCATED
  • SMALL-CAP
Category%
MID-CAP59
UNALLOCATED33.8
SMALL-CAP6.9

Stocks belong to which Index?

About 65.9% of the stocks held by ALETHEA CAPITAL MANAGEMENT, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
Index%
RUSSELL 200065.9
Others33.8
Top 5 Winners (%)%
TGB
taseko mines ltd
14.0 %
BIL
spdr series trust
0.2 %
Top 5 Winners ($)$
BIL
spdr series trust
0.1 M
TGB
taseko mines ltd
0.0 M
Top 5 Losers (%)%
tempus ai inc
-23.4 %
KURA
kura oncology inc
-21.1 %
IMRX
immuneering corp
-19.9 %
LPRO
open lending corp
-19.4 %
AXSM
axsome therapeutics inc.
-7.3 %
Top 5 Losers ($)$
AXSM
axsome therapeutics inc.
-9.0 M
KURA
kura oncology inc
-3.3 M
tempus ai inc
-0.4 M
SPY
state str spdr s&p 500 etf t
-0.2 M
IMRX
immuneering corp
0.0 M

ALETHEA CAPITAL MANAGEMENT, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of ALETHEA CAPITAL MANAGEMENT, LLC

ALETHEA CAPITAL MANAGEMENT, LLC has 13 stocks in it's portfolio. About 95.4% of the portfolio is in top 10 stocks. AXSM proved to be the most loss making stock for the portfolio. BIL was the most profitable stock for ALETHEA CAPITAL MANAGEMENT, LLC last quarter.

Last Reported on: 13 May, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions